Dermata Therapeutics, Inc. (DRMA) Insider Trading Disclosures
Dermata Therapeutics, Inc. (DRMA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DRMA
CIK: 1853816
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerStephen Fanucchi
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-3 | 2026-10-09 | — | S-3 | 0001493152-26-046518 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2025-08-16 | 4 | 0001493152-26-039048 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-16 | 4 | 0001493152-26-039046 | View SEC Doc Filr Page |
| 25-NSE | 2026-08-17 | — | 25-NSE Filing | 0001354457-26-000799 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-16 | 8-K | 0001493152-26-038647 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001493152-26-037127 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001493152-26-037124 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001493152-26-036109 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-16 | 4 | 0001493152-26-028884 | View SEC Doc Filr Page |
| S-8 | 2026-06-04 | — | S-8 | 0001493152-26-027275 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-06-01 | — | SCHEDULE 13D Filing | 0001493152-26-026642 | View SEC Doc Filr Page |
| EFFECT | 2026-05-29 | — | EFFECT Filing | 9999999995-26-001810 | View SEC Doc Filr Page |
| 424B3 | 2026-05-29 | — | 424B3 | 0001493152-26-026446 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-27 | 8-K | 0001493152-26-025441 | View SEC Doc Filr Page |
| CORRESP | 2026-05-27 | — | CORRESP Filing | 0001493152-26-025407 | View SEC Doc Filr Page |
| S-3/A | 2026-05-22 | — | S-3/A | 0001493152-26-025073 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-055876 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001493152-26-022719 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-03-31 | 8-K | 0001493152-26-022710 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-22 | — | SCHEDULE 13G/A Filing | 0000921895-26-001059 | View SEC Doc Filr Page |
| ARS | 2026-04-17 | 2025-12-31 | ARS | 0001493152-26-017912 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-17 | — | DEFA14A | 0001493152-26-017911 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-17 | 2026-04-17 | DEF 14A | 0001493152-26-017909 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-07 | 2026-04-06 | PRE 14A | 0001493152-26-015348 | View SEC Doc Filr Page |
| 10-K | 2026-03-26 | 2025-12-31 | 10-K | 0001493152-26-012992 | View SEC Doc Filr Page |